Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2024-01-15 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the company's 2024 first extraordinary general meeting of shareholders. It details the meeting date, attendance, voting results on proposals, and legal opinions from lawyers confirming the validity of the meeting and resolutions. There is no financial data or report content, only the official announcement of the voting results and meeting proceedings. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, not a full report or presentation.
2024-01-15 Chinese
第五届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 15th meeting of the 5th Board of Directors of the company. It details the meeting attendance, the approval of a proposal to adjust the convertible bond conversion price, and voting results. It is not a full annual or interim report, nor a financial statement. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and focused on board decisions, not a report or presentation. Therefore, the classification is MANG with high confidence.
2024-01-15 Chinese
第五届监事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th meeting of the 5th Supervisory Board of the company. It details the meeting attendance, the agenda items discussed, and the voting results. It includes no financial statements or detailed financial data, nor is it a transcript or presentation. The document is an official announcement of board/management decisions and approvals, specifically related to supervisory board resolutions. It is not an annual report, audit report, earnings release, or any other financial report. The content fits best under Board/Management Information (MANG) as it announces decisions made by the supervisory board, including approval of related party transactions and bank credit applications. The document length is short (1096 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-01-10 Chinese
中航证券有限公司关于健帆生物科技集团股份有限公司2024年度日常关联交易预计的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring institution (中航证券有限公司) regarding the anticipated related party transactions for the year 2024 of 健帆生物科技集团股份有限公司. It includes extensive financial data, descriptions of related parties, transaction categories, amounts, pricing principles, approvals by the board and independent directors, and the sponsor's verification opinion. The document is 7247 characters long, which is substantial and contains actual financial and operational data rather than just an announcement or certification. It is not an annual report, earnings release, or management discussion but a specific audit or verification report on related party transactions, which fits the category of an Audit Report / Information (AR). FY 2024
2024-01-10 Chinese
关于向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a comprehensive credit facility from banks, including details about the credit amount, purpose, and board approval. It does not contain financial statements or detailed financial performance data. It is a financing update related to capital structure and funding arrangements. The document length is short (1007 characters), and it is not a report publication announcement or certification. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-01-10 Chinese
第五届董事会第十四次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the 5th Board of Directors of the company. It details the meeting attendance, voting results, and specific agenda items such as approval of related party transactions and bank credit applications. It does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is clearly a Board/Management Information announcement about board decisions and approvals. The document length is short (1162 characters), and it is not an announcement of a report publication but a direct disclosure of board meeting resolutions. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-01-10 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.